Global Non-vascular Stents Market by Gastrointestinal (Colonic, Biliary, Duodenal, Pancreatic, Esophageal Stents) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Summary of the Report
In 2016, the global non-vascular market for stents was worth USD 916.1 millions. It is forecast to grow at 5.1% CAGR during the forecast period. Market growth is expected to be boosted by a growing geriatric population, an increase in chronic and other diseases, as well as increased healthcare spending. Market growth is expected to be supported by an increase in minimally invasive surgery worldwide.
Geriatrics are more likely to develop chronic diseases like lung cancer and pancreatic cancer. WHO predicts that the world's 60-year-old population will increase from 841.0 million people in 2013 to more than 2.0 billion by 2050.
Globally, gastrointestinal cancers are on the rise. This will support the market for non-vascular stents. According to the GI Cancer Institute of Australia, approximately 24,000 Australians are diagnosed each year with this disease. According to statistics from the American Cancer Society, nearly 26,370 people were diagnosed with stomach cancer in America in 2016. The American Cancer Society also states that approximately 28,000 stomach cancer cases will be diagnosed in 2017.
According to the World Bank Group, per capita global healthcare spending increased by 55.0% between 1996 and 2014. The current healthcare spending in the United States is approximately 2.4 times greater than the global average. It is expected to rise by 68.0% over the next 10 years. According to the IBM Global Business Services executive reports, the per capita healthcare spending in the United States was close to USD 9,400.0 for 2014. The market is expected to grow due to this increase in per capita healthcare spending across the globe.
Product Insights
This study analyzed products from the gastrointestinal, pulmonary, or airway segments. The gastrointestinal segment can be further divided into colonic, colonic and pancreatic stents. The pulmonary stents can also be classified as silicone and metallic airway.
Due to increasing incidence of ureteral disease, such as kidney stones or renal calculi, prostate cancer and urinary tract infection around the globe, the urological segment emerged as the largest. The demand for urological devices is expected to rise due to an increase in ureteroscopy, ureterorenoscopy and lithotripsy procedures around the globe.
Over the forecast period, the CAGR for gastrointestinal stents is expected to be comparatively higher. This is due to an increasing incidence of gastrointestinal cancers such as cancers of the stomach, esophagus and gall bladder.
Over the forecast period, the market for biliary devices is expected to grow in response to the worldwide increase in biliary diseases like gallstone disease and bile duct cancer.
Regional Insights
North America had a 32.0% market share in 2016, owing to increasing rates of chronic diseases such as asthma, glaucoma and central airway obstruction in the U.S. The dominance of the region was further supported by the presence of key market players and a strong healthcare infrastructure.
Europe will also hold a significant market share due to its growing medical technology sector and rising prevalence of gastric cancer within the EU5. Asia Pacific, on the other hand, is expected to see a higher CAGR than other regions because of favorable government initiatives to use such medical devices, rising healthcare spending, and a growing geriatric population.
Market Share Insights & Key Companies
Medtronic, C. R. Bard, Inc., Boston Scientific Corporation, and ELLA CS, s.r.o. are some of the key players in this sector. ; CONMED Corporation, HOBBS MEDICAL, INC.; Cook Medical; Taewoong Medical Co., Ltd., Synchron Med Inc., and Glaukos Corporation.
These players are focused on various growth strategies, such as product launches, mergers & acquisitions, and patient awareness campaigns. Cook Medical, for example, launched the Evolution Biliary Controlled Release Uncovered Stent in the U.S. in June 2013. This stent can be used to drain blocked biliary ducts.
Market Report Scope for Non-vascular Stents
Report Attribute |
More Details |
2020 Market Size Value |
USD 1.10 Billion |
Forecast Revenues in 2025 |
USD 1.4 Billion |
Growth Rate |
CAGR of 5.1% between 2017 and 2025 |
Estimation base year |
2016 |
Historical data |
2014 - 2016 |
Forecast period |
2017 - 2025 |
Quantitative units |
Revenue in USD Millions and CAGR between 2017-2025 |
Report coverage |
Forecast revenue, company ranking and competitive landscape, growth factors and trends |
Segments covered |
Region, product |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country coverage |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Japan; China; Brazil; Mexico; South Africa |
Key companies profiled |
Medtronic; C. R. Bard, Inc., Boston Scientific Corporation; ELLA – CS, s.r.o. ; CONMED Corporation, HOBBS Medical, Inc; Cook Medical; Taewoong Medical Co., Ltd., Synchron Med Inc., Glaukos Corporation |
The scope of customization |
With purchase, you get free report customization (equivalent to up to 8 analysts working day) You can add or modify country, region and segment scope. |
Prices and purchase options |
You can get customized purchase options that meet your research needs. Explore your purchase options |
The Report Covers Certain Segments
This report provides information on the current trends and forecasts for revenue growth, as well as analysis of each sub-segment from 2014 to 2025. Up Market Research, Inc. analyzed the market for non-vascular stents based on product and geographic regions.
-
Product Outlook (Revenue USD Million, 2014-2025)
-
Gastrointestinal Stents
-
Biliary
-
Duodenal
-
Colonic
-
Pancreatic
-
Esophageal Stents
-
-
Stents for the Pulmonary (Airway).
-
Silicone Airway
-
Metallic Airway
-
-
Urological Stents
-
Other
-
-
Regional Outlook (Revenue USD Million, 2014-2025)
-
North America
-
The U.S.
-
Canada
-
-
Europe
-
Germany
-
The U.K.
-
France
-
Italy
-
Spain
-
-
Asia Pacific
-
Japan
-
China
-
-
Latin America
-
Brazil
-
Mexico
-
-
The Middle East and Africa (MEA).
-
South Africa
-
-
These are the most frequently asked questions about this report
What is the market size for non-vascular stents?b. The market for non-vascular stents was valued at USD 1.05 Billion in 2019, and is forecast to grow to USD 1.10 Billion by 2020.
What is the market growth for non-vascular stents?b. Global non-vascular stents markets are expected to grow at a compound annual rate of 5.1% between 2017 and 2025, to reach USD 1.42 Billion by 2025.
Which market segment had the largest non-vascular stents market shares?b. With a 31.77% share in 2019, North America was the market leader for non-vascular stents. This can be attributed to the increasing incidence of lung cancer, glaucoma and central airway obstruction as well as other chronic diseases such COPD and asthma.
What are the major players in the non-vascular stents marketb. b. ; CONMED Corporation, HOBBS MEDICAL, INC.; Cook Medical; Taewoong Medical Co., Ltd., Synchron Med Inc., and Glaukos Corporation.
What are the driving factors for the non-vascular stents industry?b. The market growth is driven by the growing geriatric population, rising prevalence of chronic & additional diseases, and an increase in per capita healthcare expenditure.
Up Market Research published a new report titled “Non-vascular Stents Market research report which is segmented by Gastrointestinal (Colonic, Biliary, Duodenal, Pancreatic, Esophageal Stents), By Players/Companies INC; Cook Medical; Taewoong Medical Co, Inc; Boston Scientific Corporation; ELLA - CS, Medtronic; C R Bard, Ltd; Synchron Med Inc; and Glaukos Corporation, sro; CONMED Corporation; HOBBS MEDICAL”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
Report Attributes | Report Details |
Report Title | Non-vascular Stents Market Research Report |
By Gastrointestinal | Colonic, Biliary, Duodenal, Pancreatic, Esophageal Stents |
By Companies | INC; Cook Medical; Taewoong Medical Co, Inc; Boston Scientific Corporation; ELLA - CS, Medtronic; C R Bard, Ltd; Synchron Med Inc; and Glaukos Corporation, sro; CONMED Corporation; HOBBS MEDICAL |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 230 |
Number of Tables & Figures | 161 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Non-vascular Stents Market Report Segments:
The market is segmented by Gastrointestinal (Colonic, Biliary, Duodenal, Pancreatic, Esophageal Stents).
Non-vascular Stents Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Non-vascular Stents Market
Overview of the regional outlook of the Non-vascular Stents Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Non-vascular Stents Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Non-vascular Stents Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
1. Colonic
2. Biliary
3. Duodenal
4. Pancreatic
5. Esophageal Stents
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Non-vascular Stents Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Non-vascular Stents Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Non-vascular Stents Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Non-vascular Stents Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Non-vascular Stents Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Non-vascular Stents Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Non-vascular Stents Market Size & Forecast, 2018-2028
4.5.1 Non-vascular Stents Market Size and Y-o-Y Growth
4.5.2 Non-vascular Stents Market Absolute $ Opportunity
Chapter 5 Global Non-vascular Stents Market Analysis and Forecast by Gastrointestinal
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Gastrointestinal
5.1.2 Basis Point Share (BPS) Analysis by Gastrointestinal
5.1.3 Absolute $ Opportunity Assessment by Gastrointestinal
5.2 Non-vascular Stents Market Size Forecast by Gastrointestinal
5.2.1 Colonic
5.2.2 Biliary
5.2.3 Duodenal
5.2.4 Pancreatic
5.2.5 Esophageal Stents
5.3 Market Attractiveness Analysis by Gastrointestinal
Chapter 6 Global Non-vascular Stents Market Analysis and Forecast by Region
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Region
6.1.2 Basis Point Share (BPS) Analysis by Region
6.1.3 Absolute $ Opportunity Assessment by Region
6.2 Non-vascular Stents Market Size Forecast by Region
6.2.1 North America
6.2.2 Europe
6.2.3 Asia Pacific
6.2.4 Latin America
6.2.5 Middle East & Africa (MEA)
6.3 Market Attractiveness Analysis by Region
Chapter 7 Coronavirus Disease (COVID-19) Impact
7.1 Introduction
7.2 Current & Future Impact Analysis
7.3 Economic Impact Analysis
7.4 Government Policies
7.5 Investment Scenario
Chapter 8 North America Non-vascular Stents Analysis and Forecast
8.1 Introduction
8.2 North America Non-vascular Stents Market Size Forecast by Country
8.2.1 U.S.
8.2.2 Canada
8.3 Basis Point Share (BPS) Analysis by Country
8.4 Absolute $ Opportunity Assessment by Country
8.5 Market Attractiveness Analysis by Country
8.6 North America Non-vascular Stents Market Size Forecast by Gastrointestinal
8.6.1 Colonic
8.6.2 Biliary
8.6.3 Duodenal
8.6.4 Pancreatic
8.6.5 Esophageal Stents
8.7 Basis Point Share (BPS) Analysis by Gastrointestinal
8.8 Absolute $ Opportunity Assessment by Gastrointestinal
8.9 Market Attractiveness Analysis by Gastrointestinal
Chapter 9 Europe Non-vascular Stents Analysis and Forecast
9.1 Introduction
9.2 Europe Non-vascular Stents Market Size Forecast by Country
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 U.K.
9.2.5 Spain
9.2.6 Russia
9.2.7 Rest of Europe
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 Europe Non-vascular Stents Market Size Forecast by Gastrointestinal
9.6.1 Colonic
9.6.2 Biliary
9.6.3 Duodenal
9.6.4 Pancreatic
9.6.5 Esophageal Stents
9.7 Basis Point Share (BPS) Analysis by Gastrointestinal
9.8 Absolute $ Opportunity Assessment by Gastrointestinal
9.9 Market Attractiveness Analysis by Gastrointestinal
Chapter 10 Asia Pacific Non-vascular Stents Analysis and Forecast
10.1 Introduction
10.2 Asia Pacific Non-vascular Stents Market Size Forecast by Country
10.2.1 China
10.2.2 Japan
10.2.3 South Korea
10.2.4 India
10.2.5 Australia
10.2.6 South East Asia (SEA)
10.2.7 Rest of Asia Pacific (APAC)
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Asia Pacific Non-vascular Stents Market Size Forecast by Gastrointestinal
10.6.1 Colonic
10.6.2 Biliary
10.6.3 Duodenal
10.6.4 Pancreatic
10.6.5 Esophageal Stents
10.7 Basis Point Share (BPS) Analysis by Gastrointestinal
10.8 Absolute $ Opportunity Assessment by Gastrointestinal
10.9 Market Attractiveness Analysis by Gastrointestinal
Chapter 11 Latin America Non-vascular Stents Analysis and Forecast
11.1 Introduction
11.2 Latin America Non-vascular Stents Market Size Forecast by Country
11.2.1 Brazil
11.2.2 Mexico
11.2.3 Rest of Latin America (LATAM)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Latin America Non-vascular Stents Market Size Forecast by Gastrointestinal
11.6.1 Colonic
11.6.2 Biliary
11.6.3 Duodenal
11.6.4 Pancreatic
11.6.5 Esophageal Stents
11.7 Basis Point Share (BPS) Analysis by Gastrointestinal
11.8 Absolute $ Opportunity Assessment by Gastrointestinal
11.9 Market Attractiveness Analysis by Gastrointestinal
Chapter 12 Middle East & Africa (MEA) Non-vascular Stents Analysis and Forecast
12.1 Introduction
12.2 Middle East & Africa (MEA) Non-vascular Stents Market Size Forecast by Country
12.2.1 Saudi Arabia
12.2.2 South Africa
12.2.3 UAE
12.2.4 Rest of Middle East & Africa (MEA)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Middle East & Africa (MEA) Non-vascular Stents Market Size Forecast by Gastrointestinal
12.6.1 Colonic
12.6.2 Biliary
12.6.3 Duodenal
12.6.4 Pancreatic
12.6.5 Esophageal Stents
12.7 Basis Point Share (BPS) Analysis by Gastrointestinal
12.8 Absolute $ Opportunity Assessment by Gastrointestinal
12.9 Market Attractiveness Analysis by Gastrointestinal
Chapter 13 Competition Landscape
13.1 Non-vascular Stents Market: Competitive Dashboard
13.2 Global Non-vascular Stents Market: Market Share Analysis, 2019
13.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
13.3.1 INC; Cook Medical; Taewoong Medical Co
13.3.2 Inc; Boston Scientific Corporation; ELLA - CS
13.3.3 Medtronic; C R Bard
13.3.4 Ltd; Synchron Med Inc; and Glaukos Corporation
13.3.5 sro; CONMED Corporation; HOBBS MEDICAL